Artelo Biosciences Inc at Ladenburg Thalmann Virtual Healthcare Conference Transcript
My name is Michael Higgins, senior biotech analyst here at Ladenburg Thalmann. Thanks for joining us at our virtual healthcare conference. Very pleased to introduce to you a company I cover, Artelo Biosciences and its CEO, Greg Gorgas. Greg is going to go through a deck of some slides. I will do a little Q&A towards the end. Thanks, Greg, for joining us.
It's great to be here at the Ladenburg conference. Thank you, Michael, and to the rest of your team for the invitation. It's a pleasure to be with everybody today. I'm going to be talking about Artelo Biosciences. We are traded on the NASDAQ under the symbol of ARTL. We are a clinical-stage biopharmaceutical company. We are developing a portfolio of therapeutics targeting lipid signaling pathways, most notably the endocannabinoid system.
Now for some of you, Artelo is a new name, and I want to be able to go through the slide deck at a pretty good clip, but to give you a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
